Jianshan Mo
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
Papers in
- Oncology 7
- Cytokine Signaling Pathways and Interactions 5
-
- RNA modifications and cancer 2
- Co-authors
- Xiaolei Zhang (14 shared papers)Shumin Ouyang (11 shared papers)Yuanxiang Wang (5 shared papers)Kai Zhu (4 shared papers)Wen Ding (4 shared papers)Huaxuan Li (2 shared papers)Ziyou Lin (3 shared papers)Peibin Yue (7 shared papers)
- Journals
- Acta Pharmacologica Sinica (2 papers)Journal of Medicinal Chemistry (2 papers)Theranostics (1 paper)Advanced Science (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Jianshan Mo
14 papers receiving 515 citations
Jianshan Mo's Hit Papers
Peers
Comparison fields: 5 of 57
- Cancer Research 136
- Pulmonary and Respiratory Medicine 239
- Oncology 146
- Molecular Biology 224
- Pathology and Forensic Medicine 51
Countries citing papers authored by Jianshan Mo
This map shows the geographic impact of Jianshan Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianshan Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianshan Mo more than expected).
Fields of papers citing papers by Jianshan Mo
This network shows the impact of papers produced by Jianshan Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianshan Mo. The network helps show where Jianshan Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianshan Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer Hit paper breakdown → | 2022 | 356 |
| 2 | 2020 | 73 | |
| 3 | 2021 | 28 | |
| 4 | 2023 | 18 | |
| 5 | 2021 | 9 | |
| 6 | 2022 | 9 | |
| 7 | 2024 | 8 | |
| 8 | 2025 | 7 | |
| 9 | 2023 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2025 | 3 | |
| 12 | 2025 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 0 |
About Jianshan Mo
Jianshan Mo is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Organic Chemistry and Immunology, having authored 15 papers that have together received 522 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), Cancer Mechanisms and Therapy (4 papers), Adenosine and Purinergic Signaling (2 papers), Synthesis and biological activity (2 papers), Phagocytosis and Immune Regulation (2 papers), RNA modifications and cancer (2 papers), Ferroptosis and cancer prognosis (1 paper) and Corneal Surgery and Treatments (1 paper). The work is most often cited by research in Cancer Research (136 citations), Pulmonary and Respiratory Medicine (239 citations), Oncology (146 citations), Molecular Biology (224 citations) and Pathology and Forensic Medicine (51 citations). Jianshan Mo has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xiaolei Zhang, Shumin Ouyang, Yuanxiang Wang, Kai Zhu, Wen Ding, Huaxuan Li, Ziyou Lin, Peibin Yue, Linlin Lou and Peiqing Liu. Their work appears in journals such as Acta Pharmacologica Sinica, Journal of Medicinal Chemistry, Theranostics, Advanced Science and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.